Development	O
of	O
a	O
mouse	O
model	O
for	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
with	O
endometrial	B-Cancer
cancer	I-Cancer
.	O

Controlling	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
is	O
currently	O
a	O
key	O
issue	O
in	O
cancer	B-Cancer
therapy	O
.	O

Lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
is	O
one	O
of	O
the	O
most	O
important	O
prognostic	O
factors	O
in	O
various	O
types	O
of	O
cancers	B-Cancer
,	O
including	O
endometrial	B-Cancer
cancer	I-Cancer
.	O

Vascular	O
endothelial	O
growth	O
factor	O
-	O
C	O
(	O
VEGF	O
-	O
C	O
)	O
plays	O
a	O
crucial	O
role	O
in	O
lymphangiogenesis	O
,	O
and	O
is	O
implicated	O
to	O
play	O
an	O
important	O
role	O
in	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
.	O

To	O
evaluate	O
the	O
role	O
of	O
VEGF	O
-	O
C	O
in	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
,	O
we	O
developed	O
an	O
animal	O
model	O
by	O
using	O
an	O
endometrial	B-Cell
cancer	I-Cell
cell	I-Cell
line	I-Cell
,	O
HEC1A	B-Cell
.	O

This	O
cell	B-Cell
line	I-Cell
is	O
not	O
invasive	O
by	O
nature	O
and	O
secretes	O
moderate	O
amounts	O
of	O
VEGF	O
-	O
C	O
;	O
intrauterine	B-Immaterial_anatomical_entity
injection	O
of	O
HEC1A	B-Cell
cells	I-Cell
into	O
Balb	O
/	O
c	O
nude	O
mice	O
resulted	O
in	O
uterine	B-Cancer
cancer	I-Cancer
with	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
after	O
8	O
weeks	O
.	O

To	O
analyze	O
the	O
contribution	O
of	O
VEGF	O
-	O
C	O
to	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
,	O
its	O
corresponding	O
gene	O
was	O
stably	O
introduced	O
into	O
HEC1A	B-Cell
cells	I-Cell
(	O
HEC1A	B-Cell
/	O
VEGF	O
-	O
C	O
)	O
,	O
which	O
then	O
produced	O
more	O
than	O
10	O
times	O
the	O
amount	O
of	O
VEGF	O
-	O
C	O
.	O

The	O
number	O
of	O
lymph	B-Cancer
node	I-Cancer
metastases	I-Cancer
was	O
significantly	O
higher	O
in	O
HEC1A	B-Cell
/	I-Cell
VEGF	I-Cell
-	I-Cell
C	I-Cell
cells	I-Cell
than	O
in	O
HEC1A	B-Cell
cells	I-Cell
(	O
3	O
.	O
2	O
vs	O
1	O
.	O
1	O
nodes	B-Multi-tissue_structure
/	O
animal	O
,	O
respectively	O
)	O
.	O

Augmented	O
lymphangiogenesis	O
was	O
observed	O
within	O
tumors	B-Cancer
when	O
HEC1A	B-Cell
/	I-Cell
VEGF	I-Cell
-	I-Cell
C	I-Cell
cells	I-Cell
were	O
inoculated	O
.	O

These	O
results	O
indicate	O
that	O
VEGF	O
-	O
C	O
plays	O
a	O
critical	O
role	O
in	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
,	O
in	O
addition	O
to	O
serving	O
as	O
a	O
platform	O
to	O
test	O
the	O
efficacy	O
of	O
various	O
therapeutic	O
modalities	O
against	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
.	O

